Literature DB >> 9576958

Processing of the Ebola virus glycoprotein by the proprotein convertase furin.

V E Volchkov1, H Feldmann, V A Volchkova, H D Klenk.   

Abstract

In the present study, we have investigated processing and maturation of the envelope glycoprotein (GP) of Ebola virus. When GP expressed from vaccinia virus vectors was analyzed by pulse-chase experiments, the mature form and two different precursors were identified. First, the endoplasmic reticulum form preGPer, full-length GP with oligomannosidic N-glycans, was detected. preGPer (110 kDa) was replaced by the Golgi-specific form preGP (160 kDa), full-length GP containing mature carbohydrates. preGP was finally converted by proteolysis into mature GP1,2, which consisted of two disulfide-linked cleavage products, the amino-terminal 140-kDa fragment GP1, and the carboxyl-terminal 26-kDa fragment GP2. GP1,2 was also identified in Ebola virions. Studies employing site-directed mutagenesis revealed that GP was cleaved at a multibasic amino acid motif located at positions 497 to 501 of the ORF. Cleavage was blocked by a peptidyl chloromethylketone containing such a motif. GP is cleaved by the proprotein convertase furin. This was indicated by the observation that cleavage did not occur when GP was expressed in furin-defective LoVo cells but that it was restored in these cells by vector-expressed furin. The Reston subtype, which differs from all other Ebola viruses by its low human pathogenicity, has a reduced cleavability due to a mutation at the cleavage site. As a result of these observations, it should now be considered that proteolytic processing of GP may be an important determinant for the pathogenicity of Ebola virus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576958      PMCID: PMC20453          DOI: 10.1073/pnas.95.10.5762

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Atomic structure of the ectodomain from HIV-1 gp41.

Authors:  W Weissenhorn; A Dessen; S C Harrison; J J Skehel; D C Wiley
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

2.  Emergence of subtype Zaire Ebola virus in Gabon.

Authors:  V Volchkov; V Volchkova; C Eckel; H D Klenk; M Bouloy; B LeGuenno; H Feldmann
Journal:  Virology       Date:  1997-05-26       Impact factor: 3.616

Review 3.  Host cell proteases controlling virus pathogenicity.

Authors:  H D Klenk; W Garten
Journal:  Trends Microbiol       Date:  1994-02       Impact factor: 17.079

4.  Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.

Authors:  M C Georges-Courbot; A Sanchez; C Y Lu; S Baize; E Leroy; J Lansout-Soukate; C Tévi-Bénissan; A J Georges; S G Trappier; S R Zaki; R Swanepoel; P A Leman; P E Rollin; C J Peters; S T Nichol; T G Ksiazek
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

5.  Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus.

Authors:  A Sanchez; M P Kiley; B P Holloway; D D Auperin
Journal:  Virus Res       Date:  1993-09       Impact factor: 3.303

6.  Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses.

Authors:  T Horimoto; K Nakayama; S P Smeekens; Y Kawaoka
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein.

Authors:  H Feldmann; S T Nichol; H D Klenk; C J Peters; A Sanchez
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

8.  Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin.

Authors:  M Vey; W Schäfer; B Reis; R Ohuchi; W Britt; W Garten; H D Klenk; K Radsak
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

Review 9.  Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones.

Authors:  W Garten; S Hallenberger; D Ortmann; W Schäfer; M Vey; H Angliker; E Shaw; H D Klenk
Journal:  Biochimie       Date:  1994       Impact factor: 4.079

10.  Structure of influenza haemagglutinin at the pH of membrane fusion.

Authors:  P A Bullough; F M Hughson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

View more
  217 in total

1.  Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Authors:  T Maruyama; L L Rodriguez; P B Jahrling; A Sanchez; A S Khan; S T Nichol; C J Peters; P W Parren; D R Burton
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells.

Authors:  C Sänger; E Mühlberger; E Ryabchikova; L Kolesnikova; H D Klenk; S Becker
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  A protein-based therapeutic for human cytomegalovirus infection.

Authors:  F Jean; L Thomas; S S Molloy; G Liu; M A Jarvis; J A Nelson; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  Functional importance of the coiled-coil of the Ebola virus glycoprotein.

Authors:  S Watanabe; A Takada; T Watanabe; H Ito; H Kida; Y Kawaoka
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Furin is involved in baculovirus envelope fusion protein activation.

Authors:  Marcel Westenberg; Hualin Wang; Wilfred F J IJkel; Rob W Goldbach; Just M Vlak; Douwe Zuidema
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Authors:  Gabriele Neumann; Heinz Feldmann; Shinji Watanabe; Igor Lukashevich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence.

Authors:  Graham Simmons; Rouven J Wool-Lewis; Frédéric Baribaud; Robert C Netter; Paul Bates
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Infection and activation of monocytes by Marburg and Ebola viruses.

Authors:  U Ströher; E West; H Bugany; H D Klenk; H J Schnittler; H Feldmann
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Authors:  L D Jasenosky; G Neumann; I Lukashevich; Y Kawaoka
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

10.  Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Authors:  Rachel L Kaletsky; Joseph R Francica; Caroline Agrawal-Gamse; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.